CINECA IRIS Institutional Research Information System

BONUCCELLI, UBALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.363
AS - Asia 16.023
EU - Europa 13.662
SA - Sud America 2.200
AF - Africa 669
OC - Oceania 86
Continente sconosciuto - Info sul continente non disponibili 13
Totale 70.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.395
SG - Singapore 4.947
IT - Italia 4.868
CN - Cina 4.616
HK - Hong Kong 2.756
SE - Svezia 1.950
BR - Brasile 1.845
VN - Vietnam 1.299
DE - Germania 1.297
BG - Bulgaria 1.199
CA - Canada 827
GB - Regno Unito 773
TR - Turchia 681
FI - Finlandia 653
FR - Francia 630
RU - Federazione Russa 601
UA - Ucraina 573
KR - Corea 520
IN - India 324
AT - Austria 320
CH - Svizzera 235
CI - Costa d'Avorio 206
JP - Giappone 187
NG - Nigeria 143
BD - Bangladesh 123
AR - Argentina 113
NL - Olanda 113
PL - Polonia 102
IQ - Iraq 91
ZA - Sudafrica 84
MX - Messico 79
SN - Senegal 76
ES - Italia 75
BE - Belgio 70
AU - Australia 69
ID - Indonesia 54
PK - Pakistan 53
CO - Colombia 48
EC - Ecuador 47
VE - Venezuela 44
UZ - Uzbekistan 41
SA - Arabia Saudita 40
MA - Marocco 38
JO - Giordania 30
CZ - Repubblica Ceca 29
IL - Israele 29
KE - Kenya 28
EG - Egitto 27
CL - Cile 26
IE - Irlanda 26
LT - Lituania 26
TW - Taiwan 24
PE - Perù 23
PY - Paraguay 23
PH - Filippine 21
MY - Malesia 20
GR - Grecia 19
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
IR - Iran 17
NZ - Nuova Zelanda 17
AZ - Azerbaigian 16
RO - Romania 16
OM - Oman 15
UY - Uruguay 15
BO - Bolivia 12
DZ - Algeria 12
JM - Giamaica 12
KZ - Kazakistan 12
NP - Nepal 12
HU - Ungheria 11
BJ - Benin 10
EU - Europa 10
PT - Portogallo 10
AM - Armenia 9
DK - Danimarca 9
GE - Georgia 9
KG - Kirghizistan 9
LB - Libano 9
PA - Panama 8
RS - Serbia 8
CR - Costa Rica 7
HN - Honduras 7
TT - Trinidad e Tobago 7
AL - Albania 6
EE - Estonia 6
ET - Etiopia 6
HR - Croazia 6
LV - Lettonia 6
BH - Bahrain 5
BN - Brunei Darussalam 5
LK - Sri Lanka 5
PS - Palestinian Territory 5
QA - Qatar 5
BY - Bielorussia 4
MD - Moldavia 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
DO - Repubblica Dominicana 3
Totale 69.946
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.155
Ashburn 3.768
Fairfield 3.473
Ann Arbor 2.740
Hong Kong 2.717
Singapore 2.645
Houston 2.595
Chandler 2.014
San Jose 1.553
Seattle 1.470
Dallas 1.446
Serra 1.288
Santa Clara 1.276
Cambridge 1.225
Sofia 1.190
Wilmington 1.179
Milan 984
Beijing 932
Shanghai 900
New York 809
Jacksonville 781
Ottawa 692
Hefei 654
Boardman 527
Princeton 526
Seoul 493
Lawrence 462
Medford 437
Lauterbourg 401
Los Angeles 395
Izmir 374
Nanjing 355
Des Moines 317
Ho Chi Minh City 298
Vienna 284
Dearborn 242
Florence 227
Istanbul 223
Bern 213
Abidjan 206
Hanoi 206
Frankfurt am Main 205
Dong Ket 192
Buffalo 191
Pisa 176
Munich 175
Tokyo 170
Nanchang 158
San Diego 152
Jüchen 145
Lagos 143
São Paulo 142
Redwood City 140
Redondo Beach 139
Rome 138
Lancaster 128
London 126
Helsinki 123
Council Bluffs 122
Kunming 101
Bremen 90
Norwalk 83
Shenyang 80
Turku 79
Dakar 76
Ogden 75
Warsaw 72
Pune 66
Boulder 63
Changsha 63
Hebei 62
Orem 62
Chicago 61
Brussels 60
Belo Horizonte 59
Guangzhou 59
The Dalles 58
Columbus 56
Tianjin 49
Phoenix 47
Nuremberg 46
Rio de Janeiro 45
Baghdad 44
Düsseldorf 44
Jiaxing 44
Lucca 43
Johannesburg 41
Brooklyn 40
Fuzhou 40
Da Nang 39
Montreal 37
Washington 37
Chennai 36
Tashkent 36
Hangzhou 33
San Francisco 32
Haiphong 31
Melbourne 31
Porto Alegre 31
Amman 29
Totale 51.617
Salva come PNG Salva come JPEG
Nome #
Il fenomeno dell'abitudine del riflesso trigemino-faciale: confronto tra malattia di Parkinson e atrofia multisistemica. 543
Actigraphic sleep detection: an artificial intelligence approach 367
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 335
α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects 304
α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise 271
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 269
Thyroid hormone levels in the cerebrospinal fluid correlate with disease severity in euthyroid patients with Alzheimer's disease 268
Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study 268
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 262
Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus. 249
Descrizione di un caso di Neuromiotonia associata a tetania normocalcemica 247
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 244
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 244
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 243
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 238
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 238
Occurrence of seizures and EEG interictal epileptiform discharges in AD patients and their correlation with clinical features: a cross-sectional study 233
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. 232
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity 232
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 228
Gait dynamics in Pisa syndrome and Camptocormia: the role of stride length and hip kinematics 226
Aerobic rehabilitation program for improving muscle function in Parkinson's disease 221
Epilepsy occurrence in patients with Alzheimer's disease: clinical experience in a tertiary dementia center 219
Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline 219
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 217
The precuneus-a witness for excessive aβ gathering in alzheimer's disease pathology 217
Thyroid function and oral TRH in amyotrophic lateral sclerosis 216
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 216
Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation. 214
A case of pelvic floor myoclonic jerk syndrome. 212
Development and psychometric properties of a neuropsychological battery for mild cognitive impairment with small vessel disease: The VMCI-tuscany study 212
Cyclic alternating pattern and interictal epileptiform discharges during morning sleep after sleep deprivation in temporal lobe epilepsy 212
α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients 212
A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy. 211
Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. 211
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease 210
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study 207
Intra-arterial tissue plasminogen activator and abciximab in patients with acute basilar artery occlusion 207
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study 205
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 205
A single center study: Aβ42/p-Tau181 CSF ratio to discriminate AD from FTD in clinical setting 205
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 202
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder 202
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 202
Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily 201
Postpartum headache due to spontaneous cervical artery dissection 199
Association Between CSF Beta-Amyloid and Apathy in Early-Stage Alzheimer Disease 199
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 197
DISRUPTION OF SLEEP-WAKE CONTINUUM IN MYOTONIC DYSTROPHY TYPE I: SLEEP MACROSTRUCTURAL AND MICROSTRUCTURAL FINDINGS 197
Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients 196
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 194
Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms? 194
Reduced luteinizing hormone secretion in women with Parkinson's disease 193
Mapping Cortical Degeneration in ALS with Magnetization Transfer Ratio and Voxel-Based Morphometry 193
Sleep Disorders in an elderly population and their relationship with cognitive symptoms: an epidemiological survey 193
What Does the Brain Have to Keep Working at Its Best? Resilience Mechanisms Such as Antioxidants and Brain/Cognitive Reserve for Counteracting Alzheimer's Disease Degeneration 192
COMPARISON OF THE EFFECTS OF BARBEXACLONE AND PHENOBARBITAL ON EPILEPTIC PATIENTS 192
A case of sarcoidosis presenting as a non-specific intramedullary lesion 192
Activity-based diary for Parkinson's disease, 190
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 189
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 188
Cerebellar ataxia with complete clinical recovery and resolution of MRI lesions related to central pontine myelinolysis: case report and literature review 187
Evidences of Reduced Antioxidant Activity in Patients with Chronic Migraine and Medication-Overuse Headache 187
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 187
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 187
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 186
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 185
Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease 185
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 185
Antipsychotic drugs in Huntington's disease 184
Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats 183
Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study. 183
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 183
Relation between plasmatic and cerebrospinal fluid oxidative stress biomarkers and intrathecal ig synthesis in multiple sclerosis patients 183
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study 182
NREM sleep transient events in fronto-temporal dementia: beyond sleep stage architecture 182
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports 181
Imaging in Glucocerebrosidase-Associated Parkinsonism: Current Status and Implications for Pathophysiology. 181
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial 180
A case of comorbidity between multiple sclerosis and multiple system atrophy 180
Depressive symptoms in Parkinson's disease 180
Acute and chronic effects of clozapine in essential tremor 179
Effect of metadoxine on striatal dopamine levels in C57 black mice 179
Non-rapid eye movement sleep instability in fronto-temporal dementia 179
A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. 178
Perioperative atrial fibrillation and the long-term risk of ischemic stroke 178
Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease, 177
A whole-brain analysis in de novo Parkinson disease 177
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes 177
Levodopa in the treatment of Parkinson's disease: current controversies 176
Effect of lacosamide on sleep-wake cycle of adult patients with drug-resistant partial onset epilepsy 176
Prefrontal cortex, dopamine, and jealousy endophenotype. 176
The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia 176
Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation 176
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study 175
Dopamine agonists in the treatment of Parkinson's disease 175
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients 175
Genetics of ischaemic stroke in young adults 175
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 175
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1 175
Totale 20.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021849 0 0 0 0 0 0 0 0 0 0 244 605
2021/20224.925 85 206 101 328 992 673 97 273 338 142 262 1.428
2022/20236.192 756 746 418 522 822 832 56 465 1.012 35 438 90
2023/20244.627 637 501 562 277 621 884 182 185 80 82 197 419
2024/202512.794 56 531 145 717 957 1.140 1.017 724 1.404 1.933 1.586 2.584
2025/202613.553 978 2.061 1.726 1.161 1.372 1.385 2.311 654 602 1.143 160 0
Totale 70.786